D:A:D Steering Committee: Persons with * below (#: chair) and S.Collins, D. Pizzuti, S. Storfer, I. Weller;
D:A:D Central Coordination: S.W. Worm, C.A. Sabin, N. Friis-Møller, J. Tverland, A Sjøl (verification of primary endpoint), J.D. Lundgren;
D:A:D data managers: A. Sawitz (coordinator), M. Rickenbach, L. Fanti, E. Krum, L.Gras, S Geffard, A. Sundström, M. Delforge, E. Fontas, F. Torres, K. Petoumenos, J. Kjær.

The members of the 11 Cohorts are as follows:

ATHENA (AIDS Therapy Evaluation Project Netherlands):
Central coordination: F. de Wolf, S. Zaheri, L. Gras, M.M. Hillebregt;
Participating  physicians. Site coordinating physicians in bold (city): J.M. Prins, J.C. Bos, S.E. Geerlings, M.H. Godfried, J.M.A. Lange, J.T.M. van der Meer, F.J.B. Nellen, T. van der Poll, P. Reiss*, S.U.C. Sankatsing, M. van der Valk, J.N. Vermeulen, S.M.E. Vrouenraets, M. van Vugt, F.W.M.N. Wit (AMC, Amsterdam). G. Schreij, S. van der Geest, A. Oude Lashof, S. Lowe,  A. Verbon (Maastricht). B. Bravenboer, M.J.H. Pronk (Eindhoven).  M.E. van der Ende, H. Bax, M. van der Feltz, L.B.S. Gelinck, J.L. Nouwen, B.J.A. Rijnders, E.D. de Ruiter, L. Slobbe, C.A.M. Schurink, T.E.M.S. de Vries. (Erasmus MC, Rotterdam). J. Branger (Almere). E.F. Schippers (Leyenburg, Den Haag). P.H.P. Groeneveld, M.A. Alleman (Zwolle). R.W. ten Kate, R. Soetekouw  (Haarlem). F.P. Kroon, S.M. Arend, M.G.J. de Boer, P.J. van den Broek, J.T. van Dissel, C. van Nieuwkoop (Leiden). J.G. den Hollander (Clara, Rotterdam). W. Bronsveld, K. Pogány (Alkmaar). R. Vriesendorp, F.J.F. Jeurissen, E.M.S. Leyten (Westeinde, Den Haag). D. van Houte, M. van Vonderen (Leeuwarden).  C.H.H. ten Napel, G.J. Kootstra (Enschede). K. Brinkman, G.E.L. van den Berk, W.L. Blok, P.H.J. Frissen, W.E.M. Schouten (Onze Lieve Vrouwe Gasthuis, Amsterdam). A. van Eeden, D.W.M. Verhagen (Jan van Goyen, Amsterdam). J.W. Mulder, E.C.M. van Gorp, R. Steingrover, J. Wagenaar (Slotervaart, Amsterdam). J.R. Juttmann, M.E.E. van Kasteren (Tilburg). J. Veenstra, K..D. Lettinga (St Lucas Andreas, Amsterdam). P.P. Koopmans, A.M. Brouwer, A.S.M. Dofferhoff, R. de Groot, H.J.M. ter Hofstede, M. Keuter, A.J.A.M. van der Ven (Nijmegen). H.G. Sprenger, S. van Assen, C.J. Stek (Groningen). I.M. Hoepelman, M.M.E. Schneider, M.J.M. Bonten, P.M. Ellerbroek, C.A.J.J. Jaspers, L.J. Maarschalk-Ellerbroek, J.J. Oosterheert, E.J.G. Peters, T. Mudrikova, M.W.M. Wassenberg, S. Weijer, M.H. Hoogenwerf, J.E. Arends, E. Hoornenborg  (Utrecht). S.A. Danner, M.A. van Agtmael, W.F.W. Bierman, F.A.P. Claessen, M.E. Hillebrand, E.V. de Jong, W. Kortmann, R.M. Perenboom, E.A. bij de Vaate (VUMC, Amsterdam).  C. Richter, J. van der Berg, E.H. Gisolf (Amhem).  A.A. Tanis (Vlissingen).

Aquitaine (France):
Scientific committee: M. Dupon, M. Longy-Boursier, P. Morlat, JL. Pellegrin, JM. Ragnaud and F. Dabis;
Central coordination: F. Dabis*, G. Chêne, R. Thiébaut, S. Lawson-Ayayi, M. Bruyand, MJ. Blaizeau, M. Decoin, S. Delveaux, C. Hannapier, C. d’Ivernois, O. Leleux, B. Uwamaliya-Nziyumvira, S. Geffard, G. Palmer, D. Touchard.
Participating physicians (city): F Bonnal, S Farbos (Bayonne); M. Bonarek, F. Bonnet, N. Bernard, O. Caubet, C. Cazanave, FA Dauchy, C. De La Taille, M. Dupon, P. Duffau, H. Dutronc, C. Greib, D. Lacoste, S. Lafarie, E. Lazaro, D. Malvy, P. Mercié, P. Morlat, D. Neau, A. Ochoa, JL. Pellegrin, M. Pillot-Debelleix, T. Pistone, JM. Ragnaud, MC. Receveur, MA. Vandenhende, JF. Viallard, P. Blanco, JF. Moreau, H. Fleury, ME. Lafon, B. Masquelier, I. Pellegrin, D. Breilh, G. Miremont-Salamé. (Bordeaux); L. Caunègre, Y. Gerard, P. Loste (Dax) ; J. Ceccaldi, S. Tchamgoué (Libourne); S. De Witte (Mont de Marsan)

AHOD (Australian HIV Observational Database, Australia):
Central coordination: M. Law*, K. Petoumenos, S Marashi Pour (Sydney, New South Wales);
Participating physicians(city, state): R. Moore, S Edwards, J. Hoy, K. Watson, N. Roth, J. Nicholson (Melbourne, Victoria); M Bloch, T. Franic, D. Baker, R. McFarlane, A. Carr, D. Cooper (Sydney, New South Wales); J. Chuah, W. Fankhauser (Gold Coast, Queensland), D. Nolan, C. Forsdyke (Perth, Western Australia).

BASS (Spain):
Central coordination: G. Calvo*, F. Torres, S. Mateu (Barcelona);
Participating physicians (city): P. Domingo, M.A. Sambeat, J. Gatell, E. Del Cacho, J. Cadafalch, M. Fuster (Barcelona); C. Codina, G. Sirera, A. Vaqué (Badalona).

The Brussels St Pierre Cohort (Belgium): N. Clumeck, S. De Wit*, M. Delforge, M. Gerard, K. Kabeya, D. Konopnicki, A. Libois, M.C. Payen, Y. Van Laethem.

CPCRA (USA):
Central coordination: J. Neaton, G. Bartsch, W.M. El-Sadr*, E. Krum, G. Thompson, D. Wentworth;
Participating physicians(city, state):  R. Luskin-Hawk (Chicago, Illinois); E. Telzak (Bronx, New York); W.M. El-Sadr (Harlem, New York); D.I. Abrams (San Francisco, California); D. Cohn (Denver, Colorado); N. Markowitz (Detroit, Michigan); R. Arduino (Houston, Texas); D. Mushatt (New Orleans, Louisiana); G. Friedland (New Haven, Connecticut); G. Perez (Newark, New Jersey); E. Tedaldi (Philadelphia, Pennsylvania); E. Fisher (Richmond, Virginia); F. Gordin (Washington, DC); L.R. Crane (Detroit, Michigan); J. Sampson (Portland, Oregon); J. Baxter (Camden, New Jersey).

EuroSIDA (multinational):
Central coordination: O. Kirk*, A. Mocroft, M. Ellefson, A.N. Phillips*, J.D. Lundgren*#
Participating countries and physicians: Argentina: (M Losso), C Elias. Austria: (N Vetter), (R Zangerle). Belarus: (I Karpov), A Vassilenko, VM Mitsura, O Suetnov. Belgium: (N Clumeck) S De Wit, B Poll, R Colebunders; (L Vandekerckhove). Bosnia: (V Hadziosmanovic). Bulgaria: (K Kostov). Croatia: (I Begovac). Czech Republic: (L Machala) H Rozsypal, D Sedlacek. Denmark: (J Nielsen) G Kronborg,T Benfield, M Larsen, J Gerstoft, T Katzenstein, A-B E Hansen, P Skinhøj, C Pedersen, L Oestergaard. Estonia: (K Zilmer), Jelena Smidt. Finland: (M Ristola). France: (C Katlama), J-P Viard, P-M Girard,  JM Livrozet, P Vanhems, C Pradier, F Dabis, D Neau. Germany: (J Rockstroh), R Schmidt, J van Lunzen, O Degen, HJ Stellbrink,   S Staszewski, J Bogner, G. Fätkenheuer. Greece: (J Kosmidis) P Gargalianos, G Xylomenos, J Perdios, G Panos, A Filandras, E Karabatsaki, H Sambatakou. Hungary: (D Banhegyi).  Ireland: (F Mulcahy). Israel: (I Yust) D Turner, M Burke, S Pollack, G Hassoun, S Maayan. Italy: (A Chiesi), R Esposito, I Mazeu, C Mussini, C Arici, Ospedale Riuniti, Bergamo, R Pristera, F Mazzotta, A Gabbuti, V Vullo, M Lichtner, A Chirianni, E Montesarchio, M Gargiulo, G Antonucci, F Iacomi, P Narciso, C Vlassi, M Zaccarelli,  A Lazzarin, R Finazzi, M Galli, A Ridolfo, A d’Arminio Monforte. Latvia: (B Rozentale) P Aldins. Lithuania: (S Chaplinskas). Luxembourg: (R Hemmer), T Staub. Netherlands: (P Reiss). Norway: (J Bruun) A Maeland, V Ormaasen. Poland: (B Knysz) J Gasiorowski, A Horban, E Bakowska, D Prokopowicz, R Flisiak, A Boron-Kaczmarska, M Pynka, M Beniowski, E Mularska,  Chorzow; H Trocha, (E Jablonowska) E Malolepsza, K Wojcik. Portugal: (F Antunes) E Valadas, K Mansinho, F Maltez. Romania: (D Duiculescu). Russia: (A Rakhmanova), A Vinogradova, S Buzunova. Serbia: (D Jevtovic). Slovakia: (M Mokráš) D Staneková. Slovenia: (J Tomazic). Spain: (J González-Lahoz) V Soriano, L Martin-Carbonero, P Labarga, (S Moreno), B Clotet, A Jou, R Paredes, C Tural, J Puig, I Bravo, JM Gatell, JM Miró, P Domingo, M Gutierrez, G Mateo, MA Sambeat. Sweden: (A Karlsson), PO Persson, L Flamholc. Switzerland: (B Ledergerber) R Weber, Francioli, M Cavassini, B Hirschel, E Boffi, H Furrer, M Battegay, L Elzi. Ukraine: (E Kravchenko) N Chentsova, (G Kutsyna), (S Servitskiy), (S Antoniak), (M Krasnov) . United Kingdom: (S Barton), AM Johnson, A Phillips, MA Johnson, A Mocroft, M Murphy, J Weber, G Scullard, M Fisher, C Leen.

HivBivus (Sweden):
Central coordination: L. Morfeldt*, G. Thulin, A. Sundström
Participating physicians(city): B. Åkerlund (Huddinge); K. Koppel, A. Karlsson (Stockholm); L. Flamholc, C. Håkangård (Malmö).

The ICONA Foundation(Italy):
Central coordination: A. d’Arminio Monforte*, I. Fanti. 
Participating physicians and centres:  M. Montroni, A. Giacometti, A Costantini, A. Riva (Ancona); U. Tirelli, F. Martellotta (Aviano-PN); G. Pastore, N. Ladisa, (Bari); F. Suter, F. Maggiolo (Bergamo); F. Chiodo, G. Verucchi, C. Fiorini, (Bologna); G. Carosi, G. Cristini, C. Torti, C. Minardi, D. Bertelli (Brescia); T. Quirino, C Abeli (Busto Arsizio); P.E. Manconi, P. Piano (Cagliari); J Vecchiet, M. Farenga (Chieti); G Carnevale, S Lorenzotti (Cremona); F. Ghinelli, L. Sighinolfi (Ferrara); F. Leoncini, F. Mazzotta, M. Pozzi, S. Lo Caputo (Firenze); G. Pagano, G. Cassola, G Viscoli, A. Alessandrini, R. Piscopo (Genova); F. Soscia, L. Tacconi (Latina); A. Orani, R. Rossotto (Lecco); D Tommasi, P Congedo (Lecce); A. Chiodera, P. Castelli (Macerata); M Galli, A. Lazzarin, G. Rizzardini, I Schlacht, A. d’Arminio Monforte, AL Ridolfo, A Foschi, A Castagna, S Salpietro, S. Merli, S. Melzi, M.C. Moioli, P Cicconi, T Formenti (Milano); R. Esposito, C. Mussini (Modena); A Gori (Monza), N. Abrescia, A. Chirianni, CM Izzo, M. De Marco, R. Viglietti, E Manzillo (Napoli); C. Ferrari, P. Pizzaferri (Parma); F Baldelli, G Camanni (Perugia);  G. Magnani, M.A. Ursitti (Reggio Emilia); M. Arlotti, P. Ortolani (Rimini); R. Cauda, M Andreoni, A. Antinori, G. Antonucci,  P. Narciso, V Tozzi, V. Vullo, A. De Luca, M. Zaccarelli, R. Acinapura, P. De Longis, M.P. Trotta, M. Lichtner, F. Carletti, (Roma); M.S. Mura, G Madeddu (Sassari); P. Caramello, G. Di Perri, G.C. Orofino, (Torino); E. Raise, F. Ebo (Venezia); G. Pellizzer, D. Buonfrate (Vicenza).

The Nice Cohort (France):
Central coordination: C. Pradier*, E. Fontas, C. Caissotti
Participating physicians: P. Dellamonica, L. Bentz, E. Bernard, F. De Salvador-Guillouet, J. Durant, V. Mondain-Miton, I. Perbost, B. Prouvost-Keller, P. Pugliese, V. Rahelinirina, P.M. Roger, M. Vassallo.

SHCS (Swiss HIV Cohort Study, Switzerland):M Battegay, E Bernasconi, J Böni, HC Bucher, P Bürgisser, A Calmy, S Cattacin, M Cavassini, R Dubs, M Egger, L Elzi, M Fischer, M Flepp, A Fontana, P Francioli (President of the SHCS), H Furrer, CA Fux, M Gorgievski, HF Günthard, HH Hirsch, B Hirschel, I Hösli, C Kahlert, L Kaiser, U Karrer, C Kind, T Klimkait, B Ledergerber, G Martinetti, N Müller, D Nadal, F Paccaud, G Pantaleo, A Rauch, S Regenass, M Rickenbach, C Rudin, P Schmid, D Schultze, J Schüpbach, R Speck, BM de Tejada, P Taffé, A Telenti, A Trkola, P Vernazza, R Weber*, S Yearly.

Financial acknowledgements:
Supported by the Oversight Committee for The Evaluation of Metabolic Complications of HAART, a collaborative committee with representation from academic institutions, the European Agency for the valuation of Medicinal Products, the Food and Drug Administration, the patient community, and all pharmaceutical companies with licensed anti-HIV drugs in the U.S. market: Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, and Hoffman-LaRoche.
Supported by a grant (CURE/97-46486) from the Health Insurance Fund Council, Amstelveen, the Netherlands, to the AIDS Therapy Evaluation Project Netherlands (ATHENA); by a grant from the Agence Nationale de Recherches sur le SIDA (Action Coordonnée no.7, Cohortes), to the Aquitaine Cohort; AHOD is funded by the Australian Government Department of Health and Ageing and is supported in part by grants from the U.S. National Institutes of Health's National Institute of Allergey and Infectious Diseases (NIAID) grant no U01-AI069907, and the Foundation for AIDS Research; by grants from the Fondo de Investigación Sanitaria (FIS 99/0887) and Fundación para la Investigación y la Prevención del SIDA en Espanã (FIPSE 3171/00), to the Barcelona Antiretroviral Surveillance Study (BASS); by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grants 5U01AI042170-10 and 5U01AI046362-03), to the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA);  by grants from the BIOMED 1 (CT94-1637) and BIOMED 2 (CT97-2713) programs and the fifth framework program (QLK2-2000-00773)of the European Commission and grants from Bristol-Myers Squibb, GlaxoSmithKline, Boehringer Ingelheim, and Roche, to the EuroSIDA study; by unrestricted educational grants of Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GSK, Pfizer, Janssen-Cilag to the Italian Cohort Naive to Antiretrovirals (The ICONA Foundation); and by a grant  from the Swiss National Science Foundation, to the Swiss HIV Cohort Study (SHCS).

Updated: 26 May 2009